Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency
- PMID: 11700497
- DOI: 10.1067/mva.2001.119503
Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency
Abstract
Purpose: Increased transforming growth factor-beta(1) (TGF-beta(1)) activity is associated with chronic venous insufficiency (CVI) disease progression and dermal skin pathology. Because TGF-beta(1) stimulates collagen synthesis and alters the levels of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), we investigated the hypothesis that increased TGF-beta(1) activity is associated with differences in messenger RNA and protein levels of MMPs and TIMP-1 in patients with CVI.
Methods: One hundred ten biopsies of the lower calf and lower thigh in 73 patients were snap frozen in liquid nitrogen and stratified into six groups according to the clinical etiologic anatomic distribution pathophysiology disease classification. One set of lower-calf and lower-thigh biopsies were analyzed for MMP-1 and TIMP-1 gene expression with quantitative reverse transcription and competitive polymerase chain reaction. A second set of biopsies was analyzed for the active and latent forms of MMP-1, MMP-2, and MMP-9 as well as for TIMP-1 by western blotting, gelatin zymography, and tissue localization by immunohistochemistry (IHC).
Results: Compared with the control, MMP-1 messenger RNA was increased in class-4 and class-6 patients (P < or =.01), whereas TIMP-1 was increased in class-6 patients only (P < or =.05). However, there were no differences in total protein between MMP-1 and TIMP-1. Active MMP-2 protein increased in class-4 and class-5 patients compared with active MMP-1 and TIMP-1 (P < or =.01). Western blotting did not identify the active component of MMP-9. Similarly, only the latent form of MMP-9 was observed by gelatin zymography, whereas both the latent and active forms of MMP-2 were observed. IHC demonstrated MMP-1 and MMP-2 in dermal fibroblasts and in perivascular leukocytes. TIMP-1 was observed in basal-layer keratinocytes of the epidermis only. MMP-9 was not detected by IHC.
Conclusion: MMP synthesis is regulated at both the transcriptional and post-transcriptional levels in CVI. Our data suggest that post-translational modifications are key to functional regulation. Dermal fibroblasts and migrating leukocytes are probable cellular sources of MMPs. Increased active MMP-2 levels in class-4 and class-5 patients indicate tissue remodeling caused by pre-ulcer and postulcer environmental stimuli. These data suggest that alterations in MMP-2 activity, in conjunction with TGF-beta(1)-mediated events, cause an imbalance in tissue remodeling leading to a pro-ulcer-forming environment.
Similar articles
-
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.J Cell Physiol. 2002 May;191(2):208-16. doi: 10.1002/jcp.10092. J Cell Physiol. 2002. PMID: 12064464
-
Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.Arthritis Rheum. 2005 Sep;52(9):2751-60. doi: 10.1002/art.21265. Arthritis Rheum. 2005. PMID: 16142742
-
Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1.Mol Hum Reprod. 2006 Dec;12(12):725-36. doi: 10.1093/molehr/gal086. Epub 2006 Oct 27. Mol Hum Reprod. 2006. PMID: 17071711
-
Human odontoblast culture method: the expression of collagen and matrix metalloproteinases (MMPs).Adv Dent Res. 2001 Aug;15:55-8. doi: 10.1177/08959374010150011401. Adv Dent Res. 2001. PMID: 12640741 Review.
-
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.Int J Mol Sci. 2020 Dec 20;21(24):9739. doi: 10.3390/ijms21249739. Int J Mol Sci. 2020. PMID: 33419373 Free PMC article. Review.
Cited by
-
Biochemical and Biological Attributes of Matrix Metalloproteinases.Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22. Prog Mol Biol Transl Sci. 2017. PMID: 28413025 Free PMC article. Review.
-
Choroidal Vein Alterations in Pachychoroid Disease With Choroidal Vascular Hyperpermeability: Evaluated by Wide-Field Indocyanine Green Angiography.Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):25. doi: 10.1167/iovs.64.11.25. Invest Ophthalmol Vis Sci. 2023. PMID: 37594451 Free PMC article.
-
Regulation of matrix contraction in chronic venous disease.Eur J Vasc Endovasc Surg. 2009 Oct;38(4):518-29. doi: 10.1016/j.ejvs.2009.05.012. Epub 2009 Jun 27. Eur J Vasc Endovasc Surg. 2009. PMID: 19560950 Free PMC article.
-
Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.Prog Mol Biol Transl Sci. 2017;147:267-299. doi: 10.1016/bs.pmbts.2017.02.003. Epub 2017 Mar 21. Prog Mol Biol Transl Sci. 2017. PMID: 28413031 Free PMC article. Review.
-
Dynamic reciprocity in the wound microenvironment.Wound Repair Regen. 2011 Mar-Apr;19(2):134-48. doi: 10.1111/j.1524-475X.2011.00673.x. Wound Repair Regen. 2011. PMID: 21362080 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous